Breathe BioMedical Inc. (BRTH)

Breathe BioMedical was planning to go public, but the IPO was withdrawn on Oct 28, 2024.

IPO Price Range

$4.00 - $6.00

Shares Offered

2,625,000

Deal Size

$13.13M

Breathe BioMedical Cash Flow Statement

Financials in millions CAD. Fiscal year is January - December.

Millions CAD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	-10.54	-8.36	-4.46	-3.97
Depreciation & Amortization	-	0.47	0.26	0.22
Share-Based Compensation	-	2.27	0.62	0.71
Other Operating Activities	4.37	0.54	0.66	0.29
Operating Cash Flow	-6.17	-5.09	-2.93	-2.75
Change in Investments	-	-	-	1.78
Other Investing Activities	-	-0.13	-0.6	-0.75
Investing Cash Flow	-0.81	-0.13	-0.6	1.02
Dividends Paid	-	-0.13	-0.6	-0.75
Share Issuance / Repurchase	-	5.43	2.76	1.71
Debt Issued / Paid	-	0.88	0.62	0.01
Other Financing Activities	8.59	0.13	0.6	0.75
Financing Cash Flow	8.59	6.31	3.38	1.72
Net Cash Flow	1.61	1.09	-0.15	-0.01
Free Cash Flow	-6.98	-5.22	-3.53	-3.5

Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).